Literature DB >> 1570849

Reducing waste of intravenous solutions.

L D Diehl1, E D Goo, L Sumiye, R Ferrell.   

Abstract

A program to minimize the waste of i.v. drug solutions is outlined, and the results of audits to determine the effectiveness of the program are presented. The program for reducing i.v. solution waste at a 500-bed acute-care center involves measures to compound admixtures for individual shifts, recycle solutions, remove unused solutions from nursing units, use a standardized administration schedule and automatic stop orders, standardize total parenteral nutrient (TPN) solutions, use commercially prepared products when possible, verify telephone orders, and prepare labile products just before use. From January 1987 to January 1990, six 30-day audits were performed to determine the number of i.v. admixtures discarded. The audits showed the hospital's average rate of waste to be 3.27%, well below other published values. The medical and surgical intensive-care units, pediatrics wards, and general medicine units accounted for most of the waste, which was largely attributable to dosage changes and stat-type drugs ordered but never used. Poor communication between the pharmacy and the nursing units also contributed to sterile product waste. Although the audits showed that waste was already at a low level, they pointed out areas for further improvement. A computer linkup that gives physicians the formulas for i.v. solutions is being set up, the list of standardized TPN solution formulas is being expanded to include condition-specific solutions, and clinical pharmacists are establishing better communication with the nursing units. By using several methods to reduce the waste of i.v. solutions, a pharmacy department has limited the rate of waste to only 3.27%.

Mesh:

Substances:

Year:  1992        PMID: 1570849

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  6 in total

1.  Survey of wastage from intravenous admixture in US hospitals.

Authors:  S W Birdwell; G E Meyer; D J Scheckelhoff; C S Giambrone; S A Iteen
Journal:  Pharmacoeconomics       Date:  1993-10       Impact factor: 4.981

2.  Identifying costs of intravenous solution wastage.

Authors:  K M Uchida; S A Iteen; N T Wong
Journal:  Pharmacoeconomics       Date:  1994-09       Impact factor: 4.981

3.  Impact of Sterile Compounding Batch Frequency on Pharmaceutical Waste.

Authors:  Ghalib Abbasi; Evan Gay
Journal:  Hosp Pharm       Date:  2017-01

4.  An Anticancer Drug Unit for the whole provincial oncologic network of Piacenza: improving safety and savings.

Authors:  Patrizia Mordenti; Stefano Vecchia; Enrico Damonti; Alessandra Riva; Monica Muroni; Maria Rosa Cordani; Gabriele Cremona; Luigi Cavanna
Journal:  Med Oncol       Date:  2015-01-09       Impact factor: 3.064

5.  Evaluation and implementation of strategies to reduce the intravenous admixture returns.

Authors:  Ahmed A Alrashed; Yahya Ali Mohzari; Syed Mohammed Basheeruddin Asdaq
Journal:  Saudi J Biol Sci       Date:  2020-11-11       Impact factor: 4.219

6.  Drug waste minimisation and cost-containment in Medical Oncology: two-year results of a feasibility study.

Authors:  Gianpiero Fasola; Marianna Aita; Luisa Marini; Alessandro Follador; Marina Tosolini; Laura Mattioni; Mauro Mansutti; Andrea Piga; Silvio Brusaferro; Giuseppe Aprile
Journal:  BMC Health Serv Res       Date:  2008-04-01       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.